Sarepta Therapeutics reported $1.1B in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 1.06M 0.78M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 35705M 305M
Avrobio Inc AVRO:US $ 15.02M 75K
Biogen BIIB:US $ 6277.4M 1.7M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Daiichi Sankyo 4568:JP Y 142973M 94M
Eli Lilly And LLY:US $ 14692M 460.9M
Esperion Therapeutics ESPR:US $ 259.08M 402K
Insmed INSM:US $ 807.11M 447K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
IONIS PHARMACEUT IONS:US $ 1247.93M 19.91M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 641M 5M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Newlink Genetics NLNK:US $ 0M 0M
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
YTE INCY:US $ 31.16M 0.23M